Cargando…

AB121. Role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis

OBJECTIVE: To evaluate the clinical efficacy of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis (IC). METHODS: Twenty-one patients with IC received intravesical sodium hyaluronate therapy under nerve block or intravenous anesthesia. Bladders were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jin-Yi, Wei, Wei, Li, Shao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Printed Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842517/ http://dx.doi.org/10.21037/tau.2016.s121

Ejemplares similares

AB057. Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/Stat3 signaling pathway
por: Ni, Yongliang, et al.
Publicado: (2017)

Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome
por: Ens, Gisela, et al.
Publicado: (2015)

AB143. Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin
por: Li, Pengchao, et al.
Publicado: (2016)

Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis
por: Li, Bingkun, et al.
Publicado: (2020)

AB070. The risk factors for intravesical recurrence after upper-tract urothelial carcinoma surgery
por: Zeng, Shuxiong, et al.
Publicado: (2018)

Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
por: Ham, Byeong Kuk, et al.
Publicado: (2012)

Effect of Transurethral Resection With Hydrodistention for the Treatment of Ulcerative Interstitial Cystitis
por: Lee, Eui Sang, et al.
Publicado: (2013)

AB152. Combination of intravesical chemotherapy and Bacillus Calmette-Guerin versus Bacillus Calmette-Guerin monotherapy in intermediate- and high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis
por: Cui, Jianfeng, et al.
Publicado: (2016)

Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2016)

AB168. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer
por: Wu, Song, et al.
Publicado: (2016)

AB260. Role of µ, κ, and δ opioid receptors in tibial inhibition of bladder overactivity in cats
por: Zhang, Zhaocun, et al.
Publicado: (2016)

Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model
por: Sahiner, Ilker Fatih, et al.
Publicado: (2018)

Comparison of bladder autoaugmentation by transurethral vesicomyotomy and hydrodistention for ketamine cystitis
por: Tan, Shuo, et al.
Publicado: (2021)

AB208. Can bladder irrigation reduce the morbidity of bladder stones in patients with spinal cord injury?
por: Chen, H, et al.
Publicado: (2016)

AB161. Rottlerin-induced autophagy leads to the apoptosis in bladder cancer cells
por: Qi, Ping, et al.
Publicado: (2016)

AB138. Experience on thulium laser treatment in transurethral resection of bladder tumor
por: Gan, Xiuguo, et al.
Publicado: (2016)

AB066. The diagnostic value of narrow-band imaging for flat bladder lesions
por: Chang, Yifan, et al.
Publicado: (2018)

AB130. The expression and clinical significance of HIF-1α in bladder urothelial carcinoma
por: Fan, Haitao
Publicado: (2016)

AB095. Transurethral holmium laser bladder tumor submucosal dissection (HoL-BTSD) for non-muscle invasive bladder cancer
por: Weiguang, Liu, et al.
Publicado: (2018)

AB150. Paraneoplastic cerebellar degeneration: an uncommon manifestation of urothelial carcinoma in situ of the urinary bladder
por: Zhu, Yaofeng, et al.
Publicado: (2016)

AB267. Association of genetic polymorphism of CCNE1 and RIP2 with bladder cancer risk
por: Liang, Enli
Publicado: (2016)

AB065. Confocal laser endomicroscopy for diagnosing malignant bladder tumour: a pilot study
por: Zhang, Zhensheng, et al.
Publicado: (2018)

AB195. Correlations among improvements in overactive bladder symptom scores (OABSS) and urinary nerve growth factor levels in overactive bladder patients
por: Yang, Bo
Publicado: (2016)

AB258. Effect and mechanism of grape seed proanthocyanidin extract (GSPE) on diabetes-induced bladder dysfunction
por: Chen, Shouzhen, et al.
Publicado: (2016)

AB237. Human adipose derived stem cells induced cell apoptosis and S phase arrest in bladder tumor
por: Yu, Xi, et al.
Publicado: (2016)

AB259. TRPV1 receptor associated with detrusor overactivity induced by partial bladder outlet obstruction in rats
por: Zhang, Zhaocun, et al.
Publicado: (2016)

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

AB160. Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in China
por: Zhu, Gongjian, et al.
Publicado: (2016)

AB099. Improvement of persistent detrusor overactivity after relief of bladder outlet obstruction treated by phytotherapeutic agent
por: Bae, Woong Jin, et al.
Publicado: (2017)

AB128. Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer
por: Liu, Yuchen, et al.
Publicado: (2016)

AB264. MiR-186 inhibits the malignant behaviours of urothelial bladder cancer cell lines by targeting HMGN5
por: Yao, Kun, et al.
Publicado: (2016)

AB153. Down-regulated expression of excision of repair cross-complementing gene 1 reduces resistance to hydroxycamptothecine in bladder cancer
por: Liu, Yili
Publicado: (2016)

AB139. Low-dose versus standard dose of bacillus Calmette-Guerin in the treatment of non-muscle invasive bladder cancer
por: Xu, Chuanliang
Publicado: (2016)

AB178. Holmium laser resection of the distal ureter and bladder cuff during radical nephroureterectomy for patients with pelvis or ureteral cancer
por: Ge, Yongchao
Publicado: (2016)

AB047. Fluid intake-to-bed time, nocturia frequency and the risk of urothelial carcinoma of the bladder: a case-control study
por: Cai, Jianfeng, et al.
Publicado: (2017)

AB192. Retroperitoneal laparoscopic ureteroplasty for retrocaval ureter—report of two cases
por: Yang, Jinyi, et al.
Publicado: (2016)

AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)

AB179. Tumor suppressor in lung cancer-1 is a prognostic predictor for the recurrence and progression of non-muscle-invasive bladder cancer
por: Chen, Yegang, et al.
Publicado: (2016)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

AB144. H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
por: Liu, Changkun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gnsk1rm6d8ne08rc8h2kpmogbv